Sales by Region

FY ended March 2026

 

  • Japan: Sales decreased 0.6%. The Company concentrated on enhancing sales activities which match each market; the acute care hospital market, the small and mid-sized hospital market, and the clinic market. The Company also focused on its consumables and services business as well as strengthening its marketing and service capabilities, creating customer value which contributed to improving medical safety, patient outcomes, and operating efficiency. Domestic sales decreased due to restraining sales of locally purchased products and lower sales of Abbott products. Sales of AEDs decreased in the PAD (public access defibrillation) market mainly due to inventory adjustment at distributors. Sales in the public hospital market also decreased, while sales in the university, private hospital, and clinic markets increased. Sales of Treatment Equipment and Patient Monitors decreased, while sales of Physiological Measuring Equipment and Other Medical Equipment increased.
  • International: Sales increased 13.1%. Sales achieved double-digit growth, because sales in all regions increased favorably. Overseas sales also increased favorably on a comparable basis excluding the currency effect and the impact of the consolidation of Ad-Tech. Sales of Physiological Measuring Equipment and Treatment Equipment increased significantly. Sales of Patient Monitors and Other Medical Equipment decreased.
     

(Years ended March 31, million yen)

2022

2023

2024

2025

2026

Domestic Sales

136,321

135,734

142,370

145,237

144,406

Overseas Sales

(Overseas Sales Ratio)

68,807

(33.5%)

70,869

(34.3%)

79,615

(35.9%)

80,187

(35.6%)

90,693

(38.6%)

Total

205,129

206,603

221,986

225,424

235,099

Overseas Sales by Geographic Segments

FY ended March 2026

 

  • North America: Sales increased 18.9%. Sales showed double-digit growth, posting a significant increase in sales of neurology products including Ad-Tech as well as favorable sales of ventilators and AEDs. Sales of Patient Monitors decreased compared to the strong growth in FY2024, while sales in the fourth quarter achieved double-digit growth.
  • Latin America: Sales increased 4.2%. Sales increased both on a yen basis and on a local currency basis, as sales in the fourth quarter achieved double-digit growth. Sales increased mainly in Paraguay and Peru.
  • Europe: Sales increased 8.7%. Sales increased favorably, especially in Turkey, the U.K., and Italy.
  • Asia & Other: Sales increased 6.3%. Sales increased favorably, especially in Southeast Asia, India, and the Middle East & Africa.

 

Overseas Sales Composition by Geographic Segments
in FY ended March 2026

Overseas Sales by Geographic Segments

Years ended March 31

(Years ended March 31, million yen)

2022

2023

2024

2025

2026

Americas

33,436

36,818

43,097

47,288

55,422

   North America

32,303

37,058

41,900

49,808

   Latin America

4,514

6,039

5,388

5,613

Europe

11,449

12,349

13,104

12,554

13,649

Asia & Other

23,921

21,701

23,413

20,344

21,621

Total

68,807

70,869

79,615

80,187

90,693

* Effective FY ended March 2024, sales in the Americas are disclosed separately for sales in North America and Latin America.

Related Links